cost-share funding agency foa title deadline discipline or ......alfred p. sloan foundation...

Funding Agency FOA Title Deadline Discipline or Keywords Award Type Award Ceiling Cost-Share

RequiredPurpose

Agency for

International

Development

7200AA20APS0000

2

The Health, Ecosystems and

Agriculture for Resilient, Thriving

Societies (HEARTH)

6/15/2020

Biodiversity

Conservation

Health

Food Security

Economic Development

Education

Energy Solutions

Climate Resilience

Cooperative

Agreement $ 10,000,000.00 Yes

USAID seeks to develop new and innovative alliances with private sector actors to achieve

market-based, cross-sectoral sustainable development outcomes that benefit biodiverse

ecosystems and the people who depend on them. Private sector actors include, but are not

limited to, local and multinational corporations, grant-making foundations, and financial

institutions. Concept papers should use integrated approaches to achieve sustainable, long-

term, landscape-scale conservation of biodiverse ecosystems and improve the well-being and

prosperity of communities that depend on them. Countries involved: Bangladesh,

Democratic Republic of the Congo, Ethiopia, Kenya, Madagascar, and Zambia.

Agency for

International

Development

APS-OAA-16-

000001

USAID and the PRIVATE SECTOR:

PARTNERING FOR IMPACT8/14/2020

Business Development

Sustainable

Development

Other

This APS is an invitation to co-creation that USAID extends to the private sector and other

organizations interested in working closely with the private sector to achieve significant and

sustainable development results and impact.APS invites and encourages other types of

organizations, including but not limited to prospective implementing partners, to engage and

work with private sector partners to identify critical development problems and develop

initial ideas about how we might work together to solve those problems. USAID encourages

such organizations to reach out to the private sector (as defined in this APS) and explore ways

in which collaboration with USAID might help all partners – businesses, NGOs, universities,

governments, donors – to more effectively solve key problems, advance our respective

interests, and achieve far greater development results and impacts.

Alfred P. Sloan

FoundationScience of Learning STEM Continuous

The goal of the program is to enhance the persistence and success of students in STEM

majors and programs through the improvement of STEM pedagogies that incorporate

evidence-based principles of how people learn and account for differences in achievement

among student groups, e.g., race/ethnicity and gender. Contact Elizabeth S. Boylan, Ph.D.,

Program Director: [email protected]

Alfred P. Sloan

Foundation

Education and Professional

Advancement for

Underrepresented Groups

Continuous

The goal of the program is to increase the diversity of higher education institutions and the

work force in STEM fields through college and university initiatives that support the education

and professional advancement of high-achieving individuals from underrepresented groups.

Contact Elizabeth S. Boylan, Ph.D., Program Director: [email protected]

Alzheimer's

Association

Alzheimer's Association Research

Grant (AARG)To be updated

Alzheimer's Disease

DementiaGrant $ 150,000.00 No

The purpose of this program is to provide newly independent investigators with funding that

will allow them to develop preliminary or pilot data, to test procedures and to develop

hypotheses. The intent is to support early-career development that will lay the groundwork

for future research grant applications to federal or other funding entities, like the National

Institutes of Health, including future proposals to the Alzheimer's Association.

Bureau of Land

ManagementL20AS00005

Oregon/Washington Master

Cultural and Paleontological

Resource Management

2/10/2020

through

7/10/2020

Heritage resources

Cultural resources

Cooperative

Agreement ~$10,000

No, but

encouraged

Broadly, the objective is to develop partnerships to improve access to, and use, of heritage

resources, and promote their educational, scientific, cultural, and recreational values in a

manner that meets U.S. Department of the Interior priorities and Cultural Heritage and

Paleontology Program goals. Individual projects shall meet one or more objectives.

UT Tyler Funding Opportunity Log 1

https://www.grants.gov/web/grants/search-grants.html?keywords=HEARTHhttps://www.grants.gov/web/grants/search-grants.html?keywords=HEARTHhttps://www.grants.gov/web/grants/search-grants.html?keywords=HEARTHhttps://www.grants.gov/web/grants/view-opportunity.html?oppId=283897https://www.grants.gov/web/grants/view-opportunity.html?oppId=283897https://sloan.org/programs/higher-educationhttps://sloan.org/programs/higher-educationhttps://sloan.org/programs/higher-educationhttps://sloan.org/programs/higher-educationhttps://www.alz.org/research/for_researchers/grants/types-of-grants/aarghttps://www.alz.org/research/for_researchers/grants/types-of-grants/aarghttps://www.grants.gov/web/grants/view-opportunity.html?oppId=322952https://www.grants.gov/web/grants/view-opportunity.html?oppId=322952https://www.grants.gov/web/grants/view-opportunity.html?oppId=322952


RequiredPurpose

Center for Disease

Control/ Dept of

Health and Human

Services

CDC-RFA-CE20-

2001Comprehensive Suicide Prevention 5/26/2020

Cooperative

Agreement $ 1,000,000.00 No

CDC’s Injury Center announces the availability of fiscal year 2020 funds to implement CDC-

RFA-CE20-2001, Comprehensive Suicide Prevention. This Notice of Funding Opportunity

(NOFO) supports implementation and evaluation of a comprehensive public health approach

to suicide prevention. Such an approach includes strong leadership as the convener of multi-

sectoral partnerships; prioritizes data to identify vulnerable populations and to better

characterize risk (e.g., relationship, job/financial, mental health problems) and protective

factors (e.g. connectedness, hope, resilience) impacting suicide; leverages current prevention

practices and fills gaps by selecting multiple and complementary strategies with the best

available evidence using CDC’s Preventing Suicide: A Technical Package of Policy, Programs,

and Practices; rigorously evaluates the overall approach and individual activities; feeds data

back into the system for quality improvement and sustainability; and effectively

communicates results. The purpose of this NOFO is to implement and evaluate this approach

to suicide prevention, with attention to vulnerable populations (e.g., veterans, tribal

populations, rural communities, LGBTQ, homeless, other) that account for a significant

proportion of the suicide burden and have suicide rates greater than the general population

in a jurisdiction(s) (e.g., state, city/county, tribe). Key outcomes include a 10% reduction in

suicide morbidity and mortality in the jurisdiction(s).

Center for Disease

Control/ Dept of

Health and Human

Services

CDC-RFA-CE20-

2002

Drug-Free Communities (DFC)

Support Program-New6/8/2020 $ 125,000.00 Yes

The purpose of the DFC Support Program is to establish and strengthen collaborations to

support the efforts of community coalitions working to prevent and reduce substance use

among youth by addressing the factors in a community that increase the risk of substance

abuse and promoting the factors that minimize the risk of substance abuse.

Department of

Agriculture

USDA-NIFA-WAMS-

007011

Women and Minorities in STEM

Fields (WAMS)1/21/2021

STEM

Agriculture

Natural Resources

Human Sciences

Grant $ 400,000.00 Yes

The purpose of this program is to support research, education/teaching, and extension

projects that increase participation by women and underrepresented minorities from rural

areas in STEM. NIFA intends this program to address educational needs within broadly

defined areas of food, agriculture, natural resources, and human (FANH) sciences.

Applications recommended for funding must highlight and emphasize the development of a

competent and qualified workforce in the FAHN sciences. WAMS-funded projects improve

the economic health and viability of rural communities by developing research and extension

initiatives that focus on new and emerging employment opportunities in STEM occupations.

Projects that contribute to the economic viability of rural communities are also encouraged.


https://www.grants.gov/web/grants/view-opportunity.html?oppId=324377https://www.grants.gov/web/grants/view-opportunity.html?oppId=324650https://www.grants.gov/web/grants/view-opportunity.html?oppId=324650https://www.grants.gov/web/grants/view-opportunity.html?oppId=323150https://www.grants.gov/web/grants/view-opportunity.html?oppId=323150


RequiredPurpose

Department of

Commerce

EDA-AUS-PL-AURO-

2018-2005546

EDA Austin FY2016-FY2019

Planning Program and Local

Technical Assistance Program

Open Economic DevelopmentCooperative

Agreement $ 300,000.00

Yes

50%

Pursuant to PWEDA, EDA announces general policies and application procedures for grant-

based investments under the Planning and Local Technical Assistance programs. Under the

Planning program EDA assists eligible recipients in creating regional economic development

plans designed to build capacity and guide the economic prosperity and resiliency of an area

or region. As part of this program, EDA supports Partnership Planning investments to facilitate

the development, implementation, revision, or replacement of Comprehensive Economic

Development Strategies (CEDS), which articulate and prioritize the strategic economic goals

of recipients’ respective regions. In general, EDA provides Partnership Planning grants to the

designated planning organization (e.g., District Organization) serving EDA designated

Economic Development Districts to enable these organizations to develop and implement

relevant CEDS. The Planning program also helps support organizations, including District

Organizations, Indian Tribes, and other eligible recipients, with Short Term and State Planning

investments designed to guide the eventual creation and retention of high-quality jobs,

particularly for the unemployed and underemployed in the Nation’s most economically

distressed regions. The Local Technical Assistance program strengthens the capacity of local

or State organizations, institutions of higher education, and other eligible recipients to

undertake and promote effective economic development programs through projects such as

feasibility analyses and impact studies.

Department of

Commerce

Economic

Development

Administration

PWEAA2020

FY 2020 EDA Public Works and

Economic Adjustment Assistance

Programs

Ongoing Economic DevelopmentCooperative

Agreement $ 3,000,000.00 Yes

Under this NOFO, EDA solicits applications from applicants in rural and urban areas to provide

investments that support construction, non-construction, technical assistance, and revolving

loan fund projects under EDA’s Public Works and EAA programs. Grants and cooperative

agreements made under these programs are designed to leverage existing regional assets and

support the implementation of economic development strategies that advance new ideas and

creative approaches to advance economic prosperity in distressed communities. EDA provides

strategic investments on a competitive- merit-basis to support economic development, foster

job creation, and attract private investment in economically distressed areas of the United

States.

Department of

Defense

Air Force

BAA-RQKPD-2015-

0001

Composite Airframe Life Extension

(CALE)10/10/2020 Composite Structures Multiple $ 800,000.00 No

The Composite Airframe Life Extension (CALE) program will concentrate on identifying,

developing, demonstrating and validating technology that will allow USAF airframe structural

integrity managers to safely extend the certified service lives of airframes currently in the

USAF fleet that contain advanced composite primary structure, without widespread

replacement of aged structure with new, and without repeating an extensive, complex

building block demonstration process. The CALE program will identify and develop

technology to know and/or predict the residual strength, durability and damage tolerance,

and reliability of advanced composite structure throughout the original, and if required new

service life of the airframe


https://www.grants.gov/web/grants/view-opportunity.html?oppId=301959https://www.grants.gov/web/grants/view-opportunity.html?oppId=301959https://www.grants.gov/web/grants/view-opportunity.html?oppId=301959https://www.grants.gov/web/grants/view-opportunity.html?oppId=321695https://www.grants.gov/web/grants/view-opportunity.html?oppId=321695https://www.grants.gov/web/grants/view-opportunity.html?oppId=321695https://www.grants.gov/web/grants/view-opportunity.html?oppId=276916https://www.grants.gov/web/grants/view-opportunity.html?oppId=276916


RequiredPurpose

Department of

Defense

Naval Information

Warfare Center Pacific

N66001-19-S-

4701

C4ISR, Information Operations,

Cyberspace Operations and

Information Technology System

Research

5/13/2020

Communications

Computers

Intelligence

Surveillance

Technology

Information Technology

Grant No

The Naval Information Warfare Center, Pacific (NIWC Pacific) is soliciting white papers and

proposals in accordance with Federal Acquisition Regulation (FAR)

6.102(d)(2), FAR 35.016 and Department of Defense Grant and Agreement Regulations

(DoDGARS) 22.315(a) which provides for competitive selection of basic research, applied

research, advanced technology development, and advanced component development and

prototype (hereinafter referred to as research). Submissions in response to this

announcement shall be for areas relating to the advancement of Command, Control,

Communications, Computers, Intelligence, Surveillance, and Reconnaissance (C4ISR)

capabilities, enabling technologies for Information Operations and Cyberspace Operations,

and Information Technology systems. Proposed research should investigate unique and

innovative approaches for defining and developing next generation integratable C4ISR

capabilities and command suites.

Department of Energy -

Office of ScienceDE-FOA-0002181

FY 2020 Continuation of Solicitation

for the Office of Science Financial

Assistance Program

9/30/2020

Scientific Computing

Basic Energy Sciences

Biological Research

Environmental Research

Fusion Energy Sciences

High Energy Physics

Nuclear Physics

Grant $ 5,000,000.00 No

The Office of Science (SC) of the Department of Energy (DOE) hereby announces its

continuing interest in receiving grant applications for support of work in the following

program areas: Advanced Scientific Computing Research, Basic Energy Sciences, Biological

and Environmental Research, Fusion Energy Sciences, High Energy Physics, and Nuclear

Physics.

Department of Health

and Human Services

Administration for

Community Living

HHS-2020-ACL-

AOA-INNU-04035/26/2020 $ 300,000.00 Yes

The purpose of this funding opportunity is to support research and documentation of

innovative and promising practices that enhance the quality, effectiveness and proven

outcomes of nutrition services programs within the aging services network. The Older

Americans Act (OAA) provides funding to States and Tribal Organizations to support a broad

array of services that enable older adults to remain in their homes and communities and

assist family and informal caregivers to care for their loved ones for as long as possible.

Research projects proposed under this grant program must have the potential for broad

implementation throughout the aging services network and have demonstrated value, i.e.,

improvements in participant well-being, cost savings, etc. Research innovations must target

services to underserved older adults with greatest social and economic need, and individuals

at risk for instit

Department of the

Interior / Fish and

Wildlife

F20AS00044Competitive State Wildlife Grant (C-

SWG) Program6/12/2020 Yes

The Competitive State Wildlife Grant (C-SWG) Program provides Federal grant funds to help

State, Commonwealth, and Territory fish and wildlife agencies and their partners implement

programs for the benefit of fish and wildlife and their habitats, including species that are not

hunted or fished. Activities must contribute directly to the implementation of a State Wildlife

Action Plan (Plan) approved by the Director of the Service or other Service designee. Priority

for use of these funds must be placed on identified species of greatest conservation need

(SGCN) and should take into consideration the relative level of funding available for the

conservation of these species. The C-SWG Program is nationally competitive. Ranking criteria

used to evaluate applications are published annually in the Notice of Funding Opportunity.

These criteria are developed in coordination with State, Commonwealth and Territory fish

and wildlife agencies and the Association of Fish and Wildlife Agencies (AFWA).


https://www.grants.gov/web/grants/view-opportunity.html?oppId=322605https://www.grants.gov/web/grants/view-opportunity.html?oppId=322605https://www.grants.gov/web/grants/view-opportunity.html?oppId=322605https://www.grants.gov/web/grants/view-opportunity.html?oppId=322605https://www.grants.gov/web/grants/view-opportunity.html?oppId=322059https://www.grants.gov/web/grants/view-opportunity.html?oppId=322059https://www.grants.gov/web/grants/view-opportunity.html?oppId=322059https://www.grants.gov/web/grants/view-opportunity.html?oppId=323596https://www.grants.gov/web/grants/view-opportunity.html?oppId=323596


RequiredPurpose

Department of

Transportation /

DOT/Federal Transit

Administration

FTA-2020-012-TRI-

AIM

Accelerating Innovative Mobility

(AIM) Challenge Grants5/18/2020 Yes

The Federal Transit Administration (FTA) announces the opportunity to apply for $11 million

in fiscal year (FY) 2019 research funds for Accelerating Innovative Mobility (AIM) Challenge

Grants in the form of cooperative agreements for eligible projects. AIM Challenge Grants are

part of FTA’s new AIM Initiative to foster innovative transit technologies, practices and

solutions that incentivize travelers to choose public transportation, promote economic

development in communities, and enhance public/private partnerships to improve personal

mobility. FTA will competitively award multiple AIM Challenge Grants to eligible recipients for

projects that can accelerate the development, implementation and adoption of innovative

technologies, practices, and service models to improve mobility and enhance the rider

experience, with a focus on innovative service delivery models, creative financing, novel

partnerships, and integrated payment solutions.

Health and Human

Services

Food and Drug

Administration

PAR-20-083

Enhancing Regulatory Science for

Advancing Pharmaceutical Quality

and Manufacturing (U01) Clinical

Trials Optional

4/10/2020

4/3/2021

4/2/2022

Drug ResearchCooperative

Agreement $ 5,000,000.00 No

The goal of this program is to support the advancement of regulatory science that can (1)

facilitate the implementation and the assessment of emerging manufacturing technology in

the pharmaceutical sector; (2) expand the knowledge base related to complex products and

formulation development, analysis, and manufacturing control to advance risk-based quality

assessment of new and generic drug products. Identified emerging technologies should be

sufficiently developed and likely ready for industrial implementation for the purpose of

product quality enhancement.

Nationa Institutes of

HealthDE-FOA-0002173 Early Career Research Program 5/1/2020

ASCR BER BES FES HEP

NPGrant $ 1,000,000.00 No

SC hereby invites grant applications for support under the Early Career Research Program in

the following program areas: Advanced Scientific Computing Research (ASCR); Biological and

Environmental Research (BER); Basic Energy Sciences (BES), Fusion Energy Sciences (FES);

High Energy Physics (HEP), and Nuclear Physics (NP). The purpose of this program is to

support the development of individual research programs of outstanding scientists early in

their careers and to stimulate research careers in the areas supported by SC.

National Archives and

Records

Administration

EDITIONS-202006

EDITIONS-202010

Publishing Historical Records in

Documentary Editions

Draft (Optional):

4/1/2020

Final deadline:

6/10/2020

Draft (optional):

8/3/2020

Final:

10/8/2020

Historical movements in

U.S. history, such as

law,politics, social

reform, business,

military, the arts and

other aspects of national

experience or on major

figures from American

history

Grant $ 175,000.00 Yes

The National Historical Publications and Records Commission seeks proposals to publish

documentary editions of historical records. Projects may focus on broad historical

movements in U.S. history, such as law (including the social and cultural history of the law),

politics, social reform, business, military, the arts, and other aspects of the national

experience, or may be centered on the papers of major figures from American history.

Whether conceived as a thematic or a biographical edition, the historical value of the records

and their expected usefulness to broad audiences must justify the costs of the project. The

Commission is especially interested in projects to commemorate the 250th anniversary of the

Declaration of Independence. We encourage applications that use collections to examine the

ideals behind the founding of the United States and the continual interpretation and debate

over those ideals over the past 250 years.

National Education

Association

Foundation

Student Success Grants6/1/2020

10/15/2020Education Grant $ 5,000.00 No

Grant funds can be used for resource materials, supplies, equipment, transportation,

technology, or scholars-in-residence. Although some funds may be used to support the

professional development necessary to implement the project, the majority of grant funds

must be spent on materials or educational experiences for students. Grant funds cannot be

used to pay indirect costs, grant administration fees, salaries, applicant stipends, conference

fees for more than one person, or lobbying or religious purposes.


https://www.grants.gov/web/grants/view-opportunity.html?oppId=325512https://www.grants.gov/web/grants/view-opportunity.html?oppId=325512https://www.grants.gov/web/grants/view-opportunity.html?oppId=323532https://www.grants.gov/web/grants/view-opportunity.html?oppId=323532https://www.grants.gov/web/grants/view-opportunity.html?oppId=323532https://www.grants.gov/web/grants/view-opportunity.html?oppId=323532https://www.grants.gov/web/grants/view-opportunity.html?oppId=322675https://www.grants.gov/web/grants/view-opportunity.html?oppId=322942https://www.grants.gov/web/grants/view-opportunity.html?oppId=322942https://www.neafoundation.org/for-educators/student-success-grants/


RequiredPurpose

National Education

Association

Foundation

Learning and Leadership Grants6/1/2020

10/15/2020

Education

STEM EducationGrant

$2,000

$5,000 No

Through our Learning & Leadership grants, we support the professional development of NEA

members by providing grants to: - Individuals to participate in high-quality professional

development like summer institutes, conferences, seminars, travel abroad programs, or

action research - Groups to fund collegial study, including study groups, action research,

lesson plan development, or mentoring experiences for faculty or staff.

National Institute of

JusticeIJ-2020-17295

Research and Evaluation of

Promising Reentry Initatives5/5/2020 $ 1,000,000.00 No

The primary goal of this solicitation is to advance the body of knowledge on promising

practices in offender reentry, in part to inform federal and other reentry-specific initiatives.

National Institute of

JusticeNIJ-2020-17170

Assessing the Effectiveness of the

Second Chance Act Grant Program:

A Phased Evaluation Approach,

Fiscal Year 2020

5/26/2020

Law, Justice and Legal

Services Science and

Technology and other

Research and

Development

$ 1,500,000.00 No

With this solicitation, NIJ requests proposals for research to evaluate the effectiveness of the

Second Chance Act (SCA) grant program in improving reentry and reducing recidivism. To

support this effort, NIJ will fund a phased research evaluation strategy that details and

measures the implementation, processes, outcomes, costs, and impacts of the grants

awarded under the SC

National Institutes of

HealthRFA-CA-20-017

Innovative Molecular and Cellular

Analysis Technologies for Basic and

Clinical Cancer Research (R21

Clinical Trials Not Allowed)

Letter of Intent

due 30 days prior

to

application

Application:

2/21/2020

5/28/2020

9/29/2020

Molecular and Cellular

Biosciences

Cancer Detection

Cancer Treatment

Grant $ 400,000.00 No

This Funding Opportunity Announcement (FOA) solicits grant applications proposing

exploratory research projects focused on the early-stage development of highly innovative

technologies offering novel molecular or cellular analysis capabilities for basic or clinical

cancer research. The emphasis of this FOA is on supporting the development of novel

capabilities involving a high degree of technical innovation for targeting, probing, or assessing

molecular and cellular features of cancer biology. Well-suited applications must offer the

potential to accelerate and/or enhance research in the areas of cancer biology, early

detection and screening, clinical diagnosis, treatment, control, epidemiology, and/or address

issues associated with cancer health disparities. Technologies proposed for development may

be intended to have widespread applicability but must be focused on improving molecular

and/or cellular characterizations of cancer biology.


HealthOVC-2020-18094 5/1/2020 Crime Grant $ 150,000,000.00 No


HealthPA-18-141

Mechanisms, Models,

Measurement, & Management in

Pain Research (R01 Clinical Trial

Optional)

6/5/2020

10/5/2020

2/5/2021

Pain Grant Not limited No

The purpose of this Funding Opportunity Announcement (FOA) is to inform the scientific

community of the pain research interests of the various Institutes and Centers (ICs) at the

National Institutes of Health (NIH) and to stimulate and foster a wide range of basic, clinical,

and translational studies on pain as they relate to the missions of these ICs. New advances

are needed in every area of pain research, from the micro perspective of molecular sciences

to the macro perspective of behavioral and social sciences. Although great strides have been

made in some areas, such as the identification of neural pathways of pain, the experience of

pain and the challenge of treatment have remained uniquely individual and unsolved.

Furthermore, our understanding of how and why individuals transition to a chronic pain state

after an acute injury is limited. Research to address these issues conducted by

interdisciplinary and multidisciplinary research teams is strongly encouraged, as is research

from underrepresented, minority, disabled, or women investigators.


https://www.neafoundation.org/for-educators/learning-and-leadership-grants/https://nij.ojp.gov/sites/g/files/xyckuh171/files/media/document/NIJ-2020-17295.pdfhttps://nij.ojp.gov/sites/g/files/xyckuh171/files/media/document/NIJ-2020-17295.pdfhttps://www.grants.gov/web/grants/view-opportunity.html?oppId=325781https://www.grants.gov/web/grants/view-opportunity.html?oppId=325781https://www.grants.gov/web/grants/view-opportunity.html?oppId=325781https://www.grants.gov/web/grants/view-opportunity.html?oppId=325781https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-017.htmlhttps://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-017.htmlhttps://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-017.htmlhttps://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-017.html


RequiredPurpose


HealthPA-18-159

Mechanisms, Models,

Measurement, & Management in

Pain Research (R21 Clinical Trial

Optional)

6/16/2020

10/16/2020

2/5/2021

Pain Grant Not limited No

The purpose of this Funding Opportunity Announcement (FOA) is to inform the scientific

community of the pain research interests of the various Institutes and Centers (ICs) at the

National Institutes of Health (NIH) and to stimulate and foster a wide range of basic, clinical,

and translational studies on pain as they relate to the missions of these ICs. New advances

are needed in every area of pain research, from the micro perspective of molecular sciences

to the macro perspective of behavioral and social sciences. Although great strides have been

made in some areas, such as the identification of neural pathways of pain, the experience of

pain and the challenge of treatment have remained uniquely individual and unsolved.

Furthermore, our understanding of how and why individuals transition to a chronic pain state

after an acute injury is limited. Research to address these issues conducted by

interdisciplinary and multidisciplinary research teams is strongly encouraged, as is research

from underrepresented, minority, disabled, or women investigators.


HealthPA-18-348

Biobehavioral and Technological

Interventions to Attenuate

Cognitive Decline in Individuals

with Cognitive Impairment or

Dementia (R01 Clinical Trial

Optional)

6/5/2020

10/5/2020Dementia Grant Not limited No

The goal of this funding opportunity announcement (FOA) is to stimulate clinical research in

order to 1) develop and test biobehavioral or technological interventions designed to

attenuate cognitive decline in individuals with Alzheimer’s or other dementias (e.g., Lewy

body dementia, vascular dementia), or disease- or age-related cognitive decline, 2) inform the

development of such interventions, and 3) elucidate the underlying mechanisms and

biomarkers associated with response to interventions. Intervention strategies include those

that restore or enhance cognitive functioning, prevent or delay the progression of cognitive

impairment, or enable individuals to compensate for, or “work around” their cognitive

deficits. This FOA is particularly interested in interventions that can be delivered in

community settings by individuals, caregivers, or others in the community.


HealthPA-20-162

Ruth L. Kirschstein National

Research Service Award (NRSA)

Short-Term Institutional Research

Training Grant (Parent T35)

5/25/2020 Grant Varies

The National Institutes of Health (NIH) will award Ruth L. Kirschstein National Research

Service Award (NRSA) Short-Term Institutional Research Training Grants (T35) to eligible,

domestic institutions to develop and/or enhance research training opportunities for

predoctoral students interested in careers in biomedical, behavioral, or clinical research.

Many NIH Institutes and Centers (ICs) use this NRSA program exclusively to support intensive,

short-term research training experiences for health professional students (medical students,

veterinary students, and/or students in other health-professional programs) during the

summer. This program is also intended to encourage training of graduate students in the

physical or quantitative sciences to pursue research careers by short-term exposure to, and

involvement in, the health-related sciences. The training should be of sufficient depth to

enable the trainees, upon completion of the program, to have a thorough exposure to the

principles underlying the conduct of biomedical research.


HealthPAR-17-052

Research Career Enhancement

Award to Advance Therapy

Development for Alzheimer's (K18)

6/12/2020

Dementia

Pharmacology

Information Science or

Systems

Alzheimers Disease

Grant See record No

This NIA Research Career Enhancement Award (K18) program invites applications from

qualified researchers to acquire training and career development experiences that close

expertise gaps in data science and in drug discovery. The goal of the program is to allow

Alzheimer's Disease (AD) researchers to expand their expertise to become more effective in

leading cross-disciplinary, translational, team-science projects in AD or AD-related dementias

(ADRD). This award will also allow data scientists to redirect their expertise toward the study

of AD and ADRD.


https://grants.nih.gov/grants/guide/pa-files/PA-18-159.htmlhttps://grants.nih.gov/grants/guide/pa-files/PA-18-159.htmlhttps://grants.nih.gov/grants/guide/pa-files/PA-18-159.htmlhttps://grants.nih.gov/grants/guide/pa-files/PA-18-159.htmlhttps://grants.nih.gov/grants/guide/pa-files/PA-20-162.htmlhttps://grants.nih.gov/grants/guide/pa-files/PA-20-162.htmlhttps://grants.nih.gov/grants/guide/pa-files/PA-20-162.htmlhttps://grants.nih.gov/grants/guide/pa-files/PA-20-162.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-17-052.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-17-052.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-17-052.html


RequiredPurpose


HealthPAR-18-261

Transition to Independent

Environmental Health Research

(TIEHR) Career Award (K01 Clinical

Trial Required)

6/12/2020

10/12/2020

2/12/2021

Biomedical Sciences

Behavioral Sciences

Environmental Health

Sciences

Grant $ 125,000.00 No

The objective of the Transitions to Independent Environmental Health Research (TIEHR)

Career Award (K01) is to provide support to outstanding biomedical basic, behavioral or

clinical investigators who are within the first 3 years of their first independent faculty

appointment to develop their independent research skills through a 3-year bridge scholar

development program for newly independent faculty. This award is intended to provide

junior faculty with pilot funding and salary support during this critical period of career

development so that the candidate can further develop his/her independent research

program and, subsequently, successfully compete for research funding in the environmental

health sciences at the completion of the award.


HealthPAR-18-291

Transition to Independent

Environmental Health Research

(TIEHR) Career Award (K01 Clinical

Trial Not Allowed)

6/12/2020

10/12/2020

2/12/2021

Biomedical Sciences

Behavioral Sciences

Environmental Health

Sciences

Grant $ 125,000.00 No

The objective of the Transitions to Independent Environmental Health Research (TIEHR)

Career Award (K01) is to provide support to outstanding biomedical basic, behavioral or

clinical investigators who are within the first 3 years of their first independent faculty

appointment to develop their independent research skills through a 3-year bridge scholar

development program for newly independent faculty. This award is intended to provide

junior faculty with pilot funding and salary support during this critical period of career

development so that the candidate can further develop his/her independent research

program and, subsequently, successfully compete for research funding in the environmental

health sciences at the completion of the award.


https://grants.nih.gov/grants/guide/pa-files/par-18-261.htmlhttps://grants.nih.gov/grants/guide/pa-files/par-18-261.htmlhttps://grants.nih.gov/grants/guide/pa-files/par-18-261.htmlhttps://grants.nih.gov/grants/guide/pa-files/par-18-261.htmlhttps://grants.nih.gov/grants/guide/pa-files/par-18-291.htmlhttps://grants.nih.gov/grants/guide/pa-files/par-18-291.htmlhttps://grants.nih.gov/grants/guide/pa-files/par-18-291.htmlhttps://grants.nih.gov/grants/guide/pa-files/par-18-291.html


RequiredPurpose


HealthPAR-18-516

Human Cell Biology of Alzheimer's

Disease Genetic Variants (R01

Clinical Trial Not Allowed)

6/7/2020

Cell Biology

Genetic Disorders

Alzheimers Disease

Molecular Cellular

Entities

Stem Cells

Human Genome

Medical Genetics

Genetics

Grant Not limited No

The goal of this FOA is to encourage research to assess, in an unbiased way, the function of

AD genetic variants themselves, not the candidate or named GWAS gene inferred to be

associated with the variant, using hIPSCs and genomic editing approaches. Assessment of non-

coding variants should include an unbiased, comprehensive molecular phenotyping approach,

for example via genomics (e.g. DNA sequencing), transcriptomics (e.g. RNAseq), epigenomics

(e.g. DNA methylation, chromatin state by ATAC-seq), RNA metabolism (e.g. miRNA,

translation) and/or proteomics. Human neurons and glial cells derived from iPSCs or via direct

reprogramming would be appropriate cell models to evaluate AD risk genetic variants.

Consideration should be given to the selection of variants to study, to genetic variant analysis

in different neural cell types and stages of maturation (see, e.g., RFA-AG-17-009: Impact of

Aging in Human Cell Models of Alzheimer's Disease (R01)), and to studying variant-relevant

cell functions in the reprogrammed and edited human cells. Functional analysis, e.g. cell

morphology, metabolism, electrophysiology, synaptic activity and/or connectivity, should be

considered in the overall characterization genotype-phenotype relationships. Development of

high-throughput genetic, molecular, and functional assays and 3D or organoid cell systems

would be complementary and important approaches to reach the goal of the FOA.

Comprehensive functional annotation of GWAS/WGS variants in non-coding regions, causality

of genotype-phenotype relationships for suspected AD gene variants, and the generation of

unbiased molecular datasets that can be integrated with genomic and physiological data in

human cells would be an outcome of this initiative.


HealthPAR-18-519

Sensory and Motor System Changes

as Predictors of Preclinical

Alzheimer's Disease (R01 Clinical

Trial Not Allowed)

6/8/2020

10/8/2020

Medical Imaging

Older People

Alzheimers Disease

Physiological or

Developmental Process

Aging

Medical Genetics

Grant No specific dollar

limit No

This FOA encourages applications investigating how functional changes in sensory systems

(olfactory, visual, auditory, somatosensory, gustatory) and/or motor systems impact the

development and progression of AD. Applications proposing to distinguish the sensory and/or

motor changes associated with early AD from those associated with normal aging are also

highly encouraged. Studies may include older adults and/or animal models and may employ a

variety of approaches, including cellular, molecular, imaging, physiological and genetic, to

address this need. Given that assessments of multiple sensory and/or motor modalities may

improve the diagnostic accuracy of preclinical AD, studies proposing to investigate a single

sensory or motor modality will not be supported.


HealthPAR-18-538

Basic and Translation Research on

Decision Making in Aging and

Alzheimer's

Disease (R21 - Clinical Trial

Optional)

2/20/2020

6/22/2020

Aging

Alzheimer's DiseaseGrant $ 275,000.00 No

This funding opportunity announcement (FOA) invites applications for basic research to

better characterize the affective, cognitive, social, and motivational parameters of impaired

and intact decision making in both normal aging and Alzheimer's disease (AD). Research is

sought that will characterize the extent to which basic behavioral and neural processes

involved in decision making are differentially impacted in normal aging and AD, investigate

the influence of social factors on decision making, and investigate the decision-making factors

that render older adults (with or without cognitive impairment) vulnerable to financial

exploitation and other forms of mistreatment and abuse.


https://grants.nih.gov/grants/guide/pa-files/PAR-18-516.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-18-516.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-18-516.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-18-519.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-18-519.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-18-519.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-18-519.htmlhttps://grants.nih.gov/grants/guide/pa-files/par-18-538.htmlhttps://grants.nih.gov/grants/guide/pa-files/par-18-538.htmlhttps://grants.nih.gov/grants/guide/pa-files/par-18-538.htmlhttps://grants.nih.gov/grants/guide/pa-files/par-18-538.htmlhttps://grants.nih.gov/grants/guide/pa-files/par-18-538.html


RequiredPurpose


HealthPAR-19-064

Mechanism for Time-Sensitive Drug

Abuse Research (R21 Clinical Trial

Optional)

6/8/2020

10/6/2020

2/8/2021

6/8/2021

10/8/2021

Substance abuse Grant $ 275,000.00 No

FOA encourages innovative scientific partnerships between researchers and community or

public partners (e.g., local departments of health, poison centers, medical examiners, health

care providers; public mental health/substance abuse or health care systems; public and

federally-charted community health clinic settings; criminal justice settings; school systems;

child welfare agencies; long-term care providers, payers, health authorities, etc.) who

confront urgent substance-related health crises or who cannot delay policy or program

changes in order to obtain baseline research data related to the implementation or impact of

such changes.


HealthPAR-19-070

Research on Current Topics in

Alzheimer's Disease and Its Related

Dementias (R01 Clinical Trial

Optional)

3/11/2020

7/9/2020

11/12/2020

Alzheimer's Disease

DementiaGrant See record No

This Funding Opportunity Announcement (FOA) is inviting applications proposing research on

current topics in Alzheimer's disease and its related dementias. Further information on the

high-priority topics of interest will be announced through a series of Notices published

subsequent to this FOA. Applicants requesting $500,000 or more in direct costs in any year

(excluding consortium F&A) must contact a Scientific/ Research Contact at least 6 weeks

before submitting the application and follow the Policy on the Acceptance for Review of

Unsolicited Applications that Request $500,000 or More in Direct Costs as described in the

SF424 (R&R) Application Guide.


HealthPAR-19-071

Research on Current Topics in

Alzheimer's Disease and Its Related

Dementias (R21 Clinical Trial Not

Allowed)

3/11/2020

7/9/2020

11/12/2020

Alzheimer's Disease


The purpose of this Funding Opportunity Announcement (FOA) is to invite applications

proposing new tests, animal models, techniques, etc. to advance research on Alzheimer's

disease and its related dementias and which need additional preliminary data with broader

dissemination to establish them for more general use in this research field. The priority topics

will be announced through a series of Notices published subsequent to this FOA.


HealthPAR-19-373

Research on biopsychosocial factors

of social connectedness and

isolation on health, wellbeing,

illness, and recovery (R01 Clinical

Trials Not Allowed)

3/17/2020

3/17/2021

Social Connectedness

Aging

Neurobiology

Behavioral Sciences


This funding opportunity announcement (FOA) solicits research projects that seek to model

the underlying mechanisms, processes, and trajectories of social relationships and how these

factors affect outcomes in health, illness, recovery, and overall wellbeing. Research areas of

interest include understanding differences and similarities between objective social

isolatedness and loneliness, how complex biopsychosocial processes are regulated in the

body, what occurs in response to dysregulation, and antecedent processes that influence

responses to the trajectories of social relationships.


HealthPAR-19-384

Research on biopsychosocial

factors of social connectedness and

isolation on health, wellbeing,

illness, and recovery (R01 Basic

Experimental Studies with Humans

Required)

3/17/2020

3/17/2021

Human Health

Social Well-Being Grant Not limited No

This funding opportunity announcement (FOA) invites research projects that seek to explain

the underlying mechanisms, processes, and trajectories of social relationships and how these

factors affect outcomes in human health, illness, recovery, and overall wellbeing. Types of

projects submitted under this FOA include studies that prospectively assign human

participants to conditions (i.e., experimentally manipulate independent variables) and that

assess biomedical and/or behavioral outcomes in humans to understand fundamental aspects

of phenomena related to social connectedness and isolatedness.


HealthPAR-20-037

Development and Application of

PET and SPECT Imaging Ligands as

Biomarkers for Drug Discovery and

for Pathophysiological Studies of

CNS Disorders (R01 Clinical Trial

Not Allowed)

6/5/2020

10/5/2020

2/5/2021

6/5/2021

10/5/2021

Tracers for molecular

targets implicated in

mental disorders and

alchohol abuse

Grant $ 275,000.00 No

This Funding Opportunity Announcement (FOA) encourages the submission of research grant

applications for the development of PET and SPECT tracers for molecular targets (e.g.,

receptors, intracellular messengers, disease-related proteins) that are implicated in mental

disorders and alcohol abuse as tools to study disease pathophysiology and/or for assessing

target engagement of potential therapeutic candidates. The objective of this FOA is to

stimulate research in the identification and development of PET and SPECT probes for

disorders of primary interest to the NIMH or NIAAA.


https://grants.nih.gov/grants/guide/pa-files/PAR-19-064.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-19-064.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-19-064.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-19-070.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-19-070.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-19-070.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-19-070.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-19-071.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-19-071.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-19-071.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-19-071.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-19-373.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-19-373.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-19-373.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-19-373.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-19-373.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-19-384.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-19-384.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-19-384.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-19-384.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-19-384.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-19-384.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-037.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-037.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-037.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-037.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-037.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-037.html


RequiredPurpose


HealthPAR-20-038

Development and Application of

PET and SPECT Imaging Ligands as

Biomarkers for Drug Discovery and

for Pathophysiological Studies of

CNS Disorders (R01 Clinical Trial

Optional)

6/5/2020

10/5/2020

2/5/2021

6/5/2021

10/5/2021

Imaging Ligands Grant Not limited No

This Funding Opportunity Announcement (FOA) invites research grant applications that

propose the development and evaluation of novel radioligands for positron emission

tomography (PET) or single photon emission computed tomography (SPECT) imaging in

human brain and the incorporation of pilot or clinical feasibility evaluation from previously

collected data in pre-clinical studies. These studies are expected to provide the requisite data

needed to advance promising PET ligands for use in clinical research.


HealthPAR-20-055

Engineering Next-Generation

Human Nervous System

Microphysiological Systems (R01


6/5/2020

10/12/2020

2/5/2021

6/5/2021

10/12/2021

Microphysiological

Systems

Nervous System


This Funding Opportunity Announcement (FOA) encourages research grant applications

directed toward developing next-generation human cell-derived microphysiological systems

(MPS) and related assays that replicate complex nervous system architectures and physiology

with improved fidelity over current capabilities. Supported projects will be expected to

enable future studies of complex nervous system development, function and aging in healthy

and disease states.


HealthPAR-20-061

Co-infection and Cancer (R21


3/17/2020

6/16/2020

10/16/2020

Infections Grant $ 275,000.00 No

The purpose of this Funding Opportunity Announcement (FOA) is to enhance mechanistic and

epidemiologic investigations addressing the roles of co-infection and cancer to shed light on

presently unestablished pathways in carcinogenesis that may inform prevention and

treatment strategies for infection-related cancers. Co-infection is defined as the occurrence

of infections by two or more infectious (pathogenic or non-pathogenic) agents – either

concurrently or sequentially – and includes both acute and chronic infections by viruses,

bacteria, parasites, and/or other microorganisms. Investigations of cancer-related to co-

infections with known oncogenic agents and of co-infections that engender novel

opportunities for prevention and treatment are appropriate. Applications where the focus is

on co-infection with Helicobacter pylori (H. pylori) and Epstein Barr virus (EBV) are of specific

interests while applications including co-infection with human immunodeficiency virus (HIV)

are not encouraged.


HealthPAR-20-062

Co-infection and Cancer (R01


3/6/2020

6/5/2020

10/05/2020

Infections Grant Not limited No

The purpose of this Funding Opportunity Announcement (FOA) is to enhance mechanistic and

epidemiologic investigations addressing the roles of co-infection and cancer to shed light on

presently unestablished pathways in carcinogenesis that may inform prevention and

treatment strategies for infection-related cancers. Co-infection is defined as the occurrence

of infections by two or more infectious (pathogenic or non-pathogenic) agents – either

concurrently or sequentially – and includes both acute and chronic infections by viruses,

bacteria, parasites, and/or other microorganisms. Investigations of cancer-related to co-

infections with known oncogenic agents and of co-infections that engender novel

opportunities for prevention and treatment are appropriate. Applications where the focus is

on co-infection with Helicobacter pylori (H. pylori) and Epstein Barr virus (EBV) are of specific

interests while applications including co-infection with human immunodeficiency virus (HIV)

are not encouraged.


HealthPAR-20-064

Archiving and Documenting Child

Health and Human Development

Data Sets (R03 Clinical Trial Not

Allowed)

6/16/2020

10/16/2020Data Archiving Grant $ 50,000.00 No

The purpose of this funding opportunity announcement (FOA) is to support the archiving and

documentation of existing data sets within the scientific mission of the Eunice Kennedy

Shriver National Institute of Child Health and Human Development (NICHD) in order to enable

secondary analysis of these data by the scientific community. The highest priority is to archive

original data collected with NICHD funding.


https://grants.nih.gov/grants/guide/pa-files/PAR-20-038.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-038.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-038.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-038.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-038.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-038.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-055.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-055.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-055.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-055.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-061.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-061.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-062.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-062.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-064.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-064.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-064.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-064.html


RequiredPurpose


HealthPAR-20-065

Small Research Grants for

Establishing Basic Science-Clinical

Collaborations to Understand

Structural Birth Defects (R03


6/16/2020

10/16/2020

Biology

Genetics

Epidemiology

Biostatistics

Bioinformatics

Grant $ 75,000.00 No

The purpose of this funding opportunity announcement (FOA) is to promote initial

establishment of basic science-clinical collaborations by providing small grants to teams of

basic scientists, physician scientists, and/or clinicians. Applications must include at least one

scientist with expertise from the basic science side of the spectrum as well as one from the

clinical side. The multiple PD/PI model is strongly encouraged but not required. The goal is to

facilitate the gathering of preliminary data to support future, larger research grant

applications that will combine expertise and integrate basic, translational, and/or clinical

approaches to understanding the developmental biology, genetics, and/or environmental

basis of structural birth defects.


HealthPAR-20-070

Research Infrastructure

Development for Interdisciplinary

Aging Studies (R21/R33 - Clinical

Trial Optional)

6/16/2020

10/16/2020Aging Grant $ 275,000.00 No

This FOA invites applications that propose to develop novel research infrastructure that will

advance the science of aging in specific areas requiring interdisciplinary partnerships or

collaborations. This FOA will use the NIH Phased Innovation Award (R21/R33) mechanism to

provide up to 2 years of R21 support for initial developmental activities and up to 3 years of

R33 support for expanded activities. Through this award, investigators will develop a

sustainable research infrastructure to support projects that address key interdisciplinary

aging research questions.


HealthPAR-20-078

Secondary Analysis of Existing

Datasets in Heart, Lung, and Blood

Diseases and Sleep Disorders (R21


2/26/2020

10/28/2020

2/26/2021

10/28/2021

2/26/2022

10/28/2022

Biomedical

BiobehavioralGrant $ 75,000.00 No

The goal of this funding opportunity is to stimulate the use of existing human datasets for

well-focused secondary analyses to investigate novel scientific ideas or new models, systems,

tools, methods, or technologies that have the potential for significant impact on biomedical

or biobehavioral research in areas relevant to the NHLBI mission. This FOA actively supports

the use of existing database resources to conduct additional analyses secondary to a project's

originally-intended primary purpose. Applications may be related to, but must be distinct

from, the specific aims of the original data collection. It will not support the collection of new

data.


HealthPAR-20-079

Surgical Disparities Research (R01 -

Clinical Trial Optional)

6/5/2020

6/5/2021

6/5/2022

Surgical Care

Clinical Interventions

Minority and Health

Disparity


The purpose of this Funding Opportunity Announcement (FOA) is to support investigative and

collaborative research focused on understanding and addressing disparities in surgical care

and outcomes, in minority and health disparity populations. While the goal is to better

understand and explore effectiveness of clinical intervention approaches for addressing

surgical disparities, this initiative will also seek to identify multi-level strategies at the

institutional and systems level.


HealthPAR-20-082

Engineering Next-Generation

Human Nervous System

Microphysiological Systems (R21


6/16/2020

10/16/2020

2/16/2021

6/16/2021

10/16/2021

Microphysiological

Systems

Nervous System

Grant $ 275,000.00 No

This Funding Opportunity Announcement (FOA) encourages research grant applications

directed toward developing next-generation human cell-derived microphysiological systems

(MPS) and related assays that replicate complex nervous system architectures and physiology

with improved fidelity over current capabilities. Supported projects will be expected to

enable future studies of complex nervous system development, function and aging in healthy

and disease states.


HealthPAR-20-153

NIH Science Education Partnership

Award (SEPA) (R25 - Clinical Trial

Not Allowed)

LOI 06/14/2020

Due Date

07/14/2020

Grant $ 250,000.00

The NIH Research Education Program (R25) supports research education activities in the

mission areas of the NIH. The overarching goal of this R25 program is to support educational

activities that complement and/or enhance the training of a workforce to meet the nation’s

biomedical, behavioral and clinical research needs.


https://grants.nih.gov/grants/guide/pa-files/PAR-20-065.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-065.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-065.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-065.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-065.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-070.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-070.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-070.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-070.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-078.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-078.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-078.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-078.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-079.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-079.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-153.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-153.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-153.html


RequiredPurpose


HealthPAR-20-154

Investigator Initiated Clinical Trials

of Complementary and Integrative

Interventions Delivered Remotely

or via mHealth (R01 Clinical Trial

Required)

6/5/2020 Grant

This Funding Opportunity Announcement (FOA) encourages applications for investigator-

initiated fully remotely delivered and conducted clinical trials to assess the efficacy or

effectiveness of complementary and integrative health interventions in NCCIH designated

areas of high research priority. Applications submitted under this FOA are expected to

propose a remotely delivered and conducted clinical trial with no in-person contact between

research staff and study participants and may utilize mHealth tools or technologies. To justify

the proposed remotely delivered efficacy or effectiveness clinical trial, applications must have

sufficient preliminary data that includes: demonstration of feasibility of remote recruitment

and accrual of participants; demonstration of participant adherence to the intervention as

well as retention of participants throughout the study; completion of final data collection

from any related studies; demonstration of the safety of the intervention; and evidence that

the intervention has promise of clinical benefit.


HealthPAR-20-155

Academic-Industrial Partnerships

(AIP) to Translate and Validate In

Vivo Imaging Systems (R01 Clinical

Trial Optional)

6/5/2020 Grant

The purpose of this Funding Opportunity Announcement (FOA) is to stimulate translation of

scientific discoveries and engineering developments in imaging, data science and/or

spectroscopic technologies into methods or tools that address contemporary problems in

understanding the fundamental biology, potential risk of development, diagnosis, treatment,

and/or disease status for cancer or other disease. A distinguishing feature of each application

to this FOA will be formation of an academic-industrial partnership: a strategic alliance of

academic and industrial investigators who work together as partners to identify and translate

a technological solution for mitigation of a cancer (or other disease-related) problem. In this

sense, the FOA acts more as funding mechanism for driving translational research in imaging

more than for a specific scientific or clinical research area. These partnerships are expected to

solidify pre-existing collaborations or new ones that would drive the field of imaging, as a

whole, further than if they had not been formed.


HealthPAR-20-156

Translational Bioinformatics

Approaches to Advance Drug

Repositioning and Combination

Therapy Development for

Alzheimer’s Disease (R01 Clinical

Trial Optional)

5/5/2020 Grant

This Funding Opportunity Announcement (FOA) enables data-driven drug repositioning and

combination therapy for Alzheimer's disease and Alzheimer's disease-related dementias

(AD/ADRD) by developing computational methods and data resources and/or integrating

computational approaches with proof-of-concept efficacy studies in cell-based models,

animal models, and/or humans.


HealthPAR-20-157

Novel Mechanism Research on

Neuropsychiatric Symptoms (NPS)

in Alzheimer's Dementia (R01


6/5/2020Alzheimer's Disease

DementiaGrant

The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for

studies that will enhance knowledge of mechanisms associated with neuropsychiatric

symptoms (NPS) in persons with Alzheimer's disease (AD) or Alzheimer's disease-related

dementias (ADRD). The findings are expected to advance mechanistic understanding of both

biobehavioral and neurobiological pathways leading to NPS. Findings may also provide insight

into novel therapeutic targets that can be advanced into interventions to treat and prevent

the development of NPS in AD and/or ADRD.


https://grants.nih.gov/grants/guide/pa-files/PAR-20-154.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-154.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-154.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-154.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-154.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-155.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-155.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-155.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-155.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-156.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-156.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-156.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-156.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-156.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-156.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-157.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-157.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-157.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-157.html


RequiredPurpose


HealthPAR-20-157





6/5/2020 Grant




dementias (ADRD). The findings are expected to advance mechanistic understanding of both



the development of NPS in AD and/or ADRD. This FOA uses the R01 mechanism, while the

companion announcement PAR-20-159 uses the R21 mechanism. High risk/high payoff

projects that lack preliminary data or utilize existing data may be most appropriate for the

R21 mechanism.


HealthPAR-20-159



in Alzheimers Dementia (R21


6/16/2020Alzheimer's Disease





dementia (ADRD). The findings are expected to advance mechanistic understanding of both



the development of NPS in AD and/or ADRD.


HealthPAR-20-159





6/16/2020 Grant $ 275,000.00




dementia (ADRD). The findings are expected to advance mechanistic understanding of both



the development of NPS in AD and/or ADRD. PAR-20-157 uses the R01 grant mechanism,

while PAR-20-159 uses the R21 mechanism. High risk/high payoff projects that lack

preliminary data or utilize existing data may be most appropriate for the R21 mechanism.


HealthPAR-20-161

Catalyzing Innovation in Pediatric

Pharmacology Clinical Trial Design

and Resource Access (X01 Clinical

Trial Not Allowed)

9/14/2020

Other: A

mechanism that

is not a grant or

cooperative

agreement

$ -

The purpose of this funding opportunity announcement (FOA) is to provide investigators with

access to a consultative resource for planning activities and concept development for single

or multi-site investigator initiated clinical trials that address gaps in pediatric drug

development and that align with priorities identified in the Best Pharmaceuticals for Children

Act (BPCA) Program. The FOA will support the development of clinical trials concepts of

future well-designed clinical trials that require non-traditional designs in pediatric

therapeutics with the opportunity to expand novelty and/or innovation. Investigators will

have access to the expertise in pediatric drug development trial designs by utilizing the

consultative services provided by the Pediatric Trials Network (PTN) and the BPCA Data

Coordinating Center.


HealthPAR-20-164

Mechanisms and Consequences of

Sleep Disparities in the U.S. (R01 -


LOI

June 14, 2020,

June 14, 2021,

June 14, 2022 Due

Dates July 14,

2020, July 14,

2021, July 14,

2022

Grant

The purpose of this Funding Opportunity Announcement (FOA) is to promote research to

understand the underlying mechanisms of sleep deficiencies among U.S. populations that

experience health disparities and how sleep deficiencies may lead to disparities in health

outcomes.


https://grants.nih.gov/grants/guide/pa-files/PAR-20-157.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-157.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-157.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-157.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-159.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-159.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-159.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-159.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-159.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-159.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-159.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-159.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-161.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-161.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-161.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-161.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-164.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-164.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAR-20-164.html


RequiredPurpose


HealthPAS-19-391

Small Research Grant Program for

the Next Generation of Researchers

in AD/ADRD Research: Area of

Focus Archiving and Leveraging

Existing Data Sets for Analyses (R03


6/16/2020

10/16/2020

Alzheimer's Disease


The overall goal of this FOA is (i) to encourage the next generation of U.S. researchers to

pursue research and academic careers in neuroscience, AD/ADRD, and healthy brain aging

and (ii) to stimulate established researchers who are not currently doing AD/ADRD research

to perform pilot studies developing new, innovative AD/ADRD research programs that

leverage and build upon their existing expertise.


HealthPAS-19-392




Focus Basic Science

(R03 Clinical Trials Not Allowed)

06/16/2020

10/16/2020

Neuroscience

Alzheimer's DiseaseGrant $ 200,000.00 No

This Small Research Grant (R03) will support important and innovative projects focused on

basic science approaches to elucidate neurodegenerative mechanisms/pathways of

Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). Proposed projects

should ultimately aim to improve the prevention, diagnosis, treatment, and/or care for

individuals with AD/ADRD. The program seeks (i) to facilitate the next generation of

researchers in the United States to pursue research and academic careers in neuroscience,

AD/ADRD, and healthy brain aging and (ii) to stimulate established researchers who are not

currently doing AD/ADRD research to perform pilot studies toward developing new,

innovative AD/ADRD research programs that leverage and build upon their existing expertise.


HealthPAS-19-393




Focus Systems Biology (R03 Clinical

Trial Not Allowed)

6/16/2020

10/16/2020

Neuroscience

Alzheimer's Disease

Healthy Brain Aging

Grant $ 200,000.00 No

The overall goal of this R03 program is (i) to facilitate the next generation of researchers in

the United States to pursue research and academic careers in neuroscience, AD/ADRD, and

healthy brain aging and (ii) to stimulate established researchers who are not currently doing

AD/ADRD research to perform pilot studies toward developing new, innovative AD/ADRD

research programs that leverage and build upon their existing expertise.


HealthPAS-20-160

Small R01s for Clinical Trials

Targeting Diseases within the

Mission of NIDDK (R01 Clinical Trial

Required)

02/05/2020

06/05/2020

10/05/2020

Grant $200,000 / per year

This Funding Opportunity Announcement encourages the submission of pilot and

feasibility clinical trials conducted in humans that will lay the foundation for larger clinical

trials related to the prevention and/or treatment of diseases and conditions within the

mission of NIDDK. The program will support small, short-term clinical trials in humans to

acquire preliminary data regarding the effects of the intervention, as well as feasibility data

related to recruitment and retention, and study conduct. Applications for clinical trials

submitted under this FOA should have clearly described aims and objectives, and have a high

likelihood that the trial findings will lead to more definitive, hypothesis-driven trialsto

improve understanding, diagnosis, prevention or treatment of the diseases studied and have

the potential to impact clinical practice and/or public health. Preliminary data regarding

intervention efficacy are not required.


HealthRFA-AG-21-002

Mechanisms of Rejuvenation and

Age-Acceleration in Heterochronic

Blood Exchange (R01 Clinical Trial

Not Allowed)

6/17/2020 Aging Grant $ 300,000.00 No

This FOA will support research on aspects of rejuvenation and accelerated aging observed

specifically in heterochronic blood exchange (HBE) experiments. The objectives are to identify

the multiple factors involved, the multiple cell types involved, and the mechanisms underlying

rejuvenation or accelerated aging that are observed in the transfer of phenotypes between

young and old laboratory animals. It is also anticipated that molecular signatures of

rejuvenation or accelerated aging will be obtained from research supported under this FOA.


https://grants.nih.gov/grants/guide/pa-files/PAS-19-391.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAS-19-391.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAS-19-391.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAS-19-391.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAS-19-391.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAS-19-391.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAS-19-392.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAS-19-392.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAS-19-392.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAS-19-392.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAS-19-392.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAS-19-393.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAS-19-393.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAS-19-393.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAS-19-393.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAS-19-393.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAS-20-160.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAS-20-160.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAS-20-160.htmlhttps://grants.nih.gov/grants/guide/pa-files/PAS-20-160.htmlhttps://grants.nih.gov/grants/guide/rfa-files/RFA-AG-21-002.htmlhttps://grants.nih.gov/grants/guide/rfa-files/RFA-AG-21-002.htmlhttps://grants.nih.gov/grants/guide/rfa-files/RFA-AG-21-002.htmlhttps://grants.nih.gov/grants/guide/rfa-files/RFA-AG-21-002.html


RequiredPurpose


Health

RFA-AG-21-007

(R35)

Outstanding

Investigator Award

Leadership Award for Alzheimer's

Disease and Related Dementias

Research (R35 Clinical Trial Not

Allowed)

Letter of Intent:

5/19/2020

(not required)

Proposal:

6/19/2020

Alzheimer's Disease


NIA is seeking applications from investigators looking to enhance their research programs to

address selected NIH Alzheimer's Disease and Related Dementias Research Implementation

Milestones. Investigators will be provided protected time to produce a program of

investigation specific to selected goals/milestones. Investigators and their institutions will also

be expected to advance more junior researchers' capacity to address selected

goals/milestones.

This leadership award will provide resources to foster outstanding scientists to expand their

potential to make significant contributions to the goals/milestones of the NIH Alzheimer's

Disease and Alzheimer's Disease Related Dementias (AD/ADRD) Summits. Applicants are

required to serve as research mentors for New Investigators and Early Stage Investigators

(NI/ESI)


HealthRFA-AG-21-010

Glial Plasticity in the Aging Brain

(R01 Clinical Trial Not Allowed)6/17/2020 Aging Grant $ 250,000.00 No

Recent reports highlight the enormous spatial and temporal diversity of glia, even within the

same glial cell type. This within-glial-cell-type heterogeneity evolves during aging, suggesting

that subtypes of glia with distinct physiological roles could emerge to influence brain aging

processes. The goal of this Funding Opportunity Announcement is to support research

addressing critical knowledge gaps in our understanding of how these glial subpopulations

could contribute to vulnerability and resilience to brain aging.


HealthRFA-CA-20-018

Advanced Development and

Validation of Emerging Molecular

and Cellular Analysis Technologies

for Basic and Clinical Cancer

Research (R33 Clinical Trials Not

Allowed)

Letter of Intent

due 30 days prior

to

application

Application:

2/21/2020

5/28/2020

9/29/2020

Molecular and Cellular

Biosciences

Cancer Detection

Cancer Treatment

Grant $ 300,000.00 No

This Funding Opportunity Announcement (FOA) solicits grant applications proposing

exploratory research projects focused on further development and validation of emerging

technologies offering novel capabilities for targeting, probing, or assessing molecular and

cellular features of cancer biology for basic or clinical cancer research. Well-suited

applications must offer the potential to accelerate and/or enhance research in the areas of

cancer biology, early detection and screening, clinical diagnosis, treatment, control,

epidemiology, and/or address issues associated with cancer health disparities. Technologies

proposed for development may be intended to have widespread applicability but must be

focused on improving molecular and/or cellular characterizations of cancer.


HealthRFA-CA-20-019

Innovative Biospecimen Science

Technologies for Basic and Clinical

Cancer Research (R21 Clinical Trials

Not Allowed)

Letter of Intent

due 30 days prior

to

app

cost-share funding agency foa title deadline discipline or ......alfred p. sloan foundation...

Documents